ARI®, and Enel X, the advanced energy services arm of the Enel Group, announced that they will collaborate with GlaxoSmithKline (GSK) to transition the healthcare company's North American fleet to 100 percent electric vehicles (EVs) by 2030. Through the pilot project, part of GSK's commitment to the EV100 initiative, ARI, a division of Holman, and Enel will help GSK implement a holistic sustainability solution that includes the deployment of electric and hybrid plug-in vehicles and installation of more than 100 charging locations. Together, ARI and Enel X, with installation support from Qmerit, are providing GSK with a turnkey fleet management and sustainability solution.

The initiative began with a thorough analysis of historical and real-time fleet data, allowing ARI and GSK to prioritize the vehicles and drivers ideally suited to transition to EV units. ARI is also facilitating the ordering and delivery of the electric and hybrid plug-in vehicles to align with the strategic charging applications provided by Enel X. The scope of the infrastructure project includes JuiceBox smart charging stations and JuiceNetFleet IoT software to help effectively manage the electric vehicle fleet. JuiceBox smart EV charging stations can be scheduled to utilize off-peak charging which delivers energy cost savings and reduces strain on the power grid during peak periods.

This provides GSK employees with a convenient, hassle-free charging experience while also reducing GSK's fleet operating costs throughout the lifecycle of the electric vehicles. Enel X has deployed approximately 230,000 charging ports worldwide and is the preferred energy services provider for more than 10,000 organizations at 35,000 locations across the globe, including fleet electrification collaborations with several industry leaders across the pharmaceutical, transportation, and energy sectors to name a few. This project with ARI highlights GSK's commitment to providing the cleanest, most convenient charging solution for its fleet and drivers.

In light of ongoing environmental concerns, a growing number of governments and organizations around the world continue to stress the importance of reaching net-zero emissions. According to the Environmental Protection Agency (EPA), the transportation sector generates the share of greenhouse gas emissions, approximately 29 percent in the United States. With corporate fleet vehicles accounting for nearly 20 percent of total registered vehicles, transitioning these units to electric vehicles is increasingly important.

Through the EV100 initiative, more than 100 organizations globally, including GlaxoSmithKline, have committed to transition nearly 5 million vehicles to EVs by 2030.